Loading...
VaccineFinder COVID-19 Vaccine Supply Reporting and Finder
For COVID -19 reporting, organizations will add COVID 19 vaccination providers and COVID 19 vaccine quantities to their existing data file and send to VaccineFinder via the usual process How the public uses VaccineFinder VaccineFinder’s goal is to make it easy for people to find a nearby location where they can be vaccinated For 11 years,
Updates to CDC COVID-19 Guidance for Correctional and
May 19, 2022 · disabilities associated with high risk of severe COVID -19 Access to COVID -19 therapeutics, or ability to transfer to community care for treatment Consider using enhanced COVID-19 prevention strategies if the facility cannot access therapeutics or transfer patients for treatment offsite Persons more likely to get very sick from COVID -19:
Note: LTC COVID-19 SOP Guidance lives outside of this toolkit
Jun 19, 2020 · • Communication Guidelines for Informing Family Members during COVID-19 (03/15/21) • COVID-19 Guidance for Hospital Discharge to Long-Term Care Facilities (10/06/21) • Hospital to Post-Acute Care Transfer COVID-19 Assessment Form (10/06/21) • CDC-Nursing Home COVID-19 Infection Control Assessment and Response (ICAR) Tool (November
National Healthcare Safety Network (NHSN)
•On the NHSN LTCF COVID-19 website, scroll to the bottom and add your e-mail address Preparing for COVID-19: Long-term Care Facilities, Nursing Homes:
US Healthcare COVID-19 Portal Job Aid Table of Contents
Jun 24, 2022 · Reporting into the U S Healthcare COVID -19 Portal Therapeutic Site Reporting a Log into the U S Healthcare COVID-19 Portal You will be able to view and edit your entries for the past 14 days Please note that, given that reporting is required weekly on Wednesdays, all other days
Searches related to how to add covid 19 to website filetype:pdf
COVID-19 claims with positive tests or diagnoses, there were only 207 disputes filed with DWC as of August 7, 2022 COVID-19 claims with benefits: During the COVID-19 pandemic (i e , March 13, 2020, through June 30, 2022), slightly more than one-third (35 ) of COVID -19 claims filed had medical or indemnity benefit payments associated with them
136781_3USHealthcareCOVID19PortalJobAid.pdf U.S. Healthcare COVID-19 Portal Job Aid
Table of Contents
PURPOSE ................................................................................................................................................................... 2
REPORTING FREQUENCY .............................................................................................................................................. 2
ADDITIONAL RESOURCES ............................................................................................................................................. 2
REQUEST FACILITY ACCESS TO U.S. HEALTHCARE COVID-19PORTAL ............................................................................................................... 3
ADD USER TO FACILITY ACCOUNT ................................................................................................................................................................. 3
REMOVE USER FROM FACILITY ACCOUNT ....................................................................................................................................................... 4
REPORTING INTO THE U.S. HEALTHCARE COVID-19 PORTAL ............................................................................................ 5
THERAPEUTIC SITE REPORTING ................................................................................................................................................................... 5
Reporting Therapeutics to the U.S. Healthcare COVID-19 Portal Last Updated June 24, 2022Page 2 of 9
Purpose
TheU.S. Healthcare COVID-19 Portal
, also referred to as the TeleTracking Portal, is a single platform throughwhich healthcare facilities across the nation report COVID-19 related data (e.g., total COVID-19 confirmed
patients,N95 inventory
, therapeutic inventory, etc.). This portal is to be used by hospital and non-hospital facilities, with the exception of Long Term Care and Skilled Nursing Facilities*. This document provides instructions on how to access and report into the portal.*Long Term Care and Skilled Nursing Facilities must report to the CDC's National Healthcare Safety Network
(NHSN), and information on enrollment and reporting can be accessed here.Reporting Frequency
Reporting use
and current inventory of COVID-19 therapeutics bamlanivimab/etesevimab (BAM/ETE), casirivimab/imdevimab (REGEN-COV), and Sotrovimab are required weekly by 11:59PM ET onWednesdays
. Please note that BAM/ETE, REGEN-COV, and Sotrovimab have had their EUAs amended to exclude them from use in any U.S. region.To return these products, please review our
Guidance on Expiring &
Expired Therapeutics.
Additional Resources
COVID-19 Portal Information Website: U.S. Healthcare COVID-19 Portal Help Phone: 1-877-570-6903 Email: Protect-ServiceDesk@hhs.gov National Healthcare Safety Network Information Website: NHSN COVID-19 Module Support Email: NHSN@cdc.gov VDH Healthcare Coordination & Therapeutics Information Website: VDH COVID-19 Therapeutics Email: COVID19Therapeutics@vdh.virginia.govPage 3 of 9
Accessing the U.S. Healthcare COVID-19 Portal
Request Facility Access to U.S. Healthcare COVID-19 Portala. Fill out this template as completely as possible, with Name, Address, and at least one of the following
identifiers: NPI, CCN, Tax ID, DEA ID, AHA ID, HHS ID, or NHSN ID . b. Send an email to hhs-protect@teletracking.com with the subject line New Therapeutic Facility Request" and attach the completed template (Note: for security reasons, it is not recommended to create an account with a public email domain (e.g., @gmail.com or yahoo.com)). c. Receive a welcome email from Protect-NoReply@hhs.gov to log into the U.S. Healthcare COVID-19Portal, which provides information on how to complete registration, invite team members, enter data,
and request assistance.Add User to Facility Account
a. Log into the U.S. Healthcare COVID-19 Portal. b. On the homepage, click Team.Page 4 of 9
c. On the Team page, scroll down and enter the required fields for each team member being added, then
clickInvite.
Remove User from Facility Account
a. Log into the U.S. Healthcare COVID-19 Portal. b. On the homepage, click Team.Page 5 of 9
c. On the Team page, to the right of the applicable user, click on the Actions drop-down menu, and select
Remove From Facility.
Reporting into the U.S. Healthcare COVID-19 PortalTherapeutic Site Reporting
a. Log into the U.S. Healthcare COVID-19 Portal. You will be able to view and edit your entries for the
past 14 days. Please note that, given that reporting is required weekly on Wednesdays, all other days
will be greyed-out for non-hospital providers as they do not require an entry. If your facility did not submit the required report, the date will show a red exclamation point and say NotCompliant.
Please be sure to go back and report the data for this week. If your facility correctly submitted the report, the date will show a green checkmark and sayCompliant.
Page 6 of 9
b. To submit a new entry, either select New Entry, click on the Pencil Icon for the applicable day, or click
+Add Entry to be redirected to the data entry page. All dates that show as "Not Compliant" should be
updated to completion.c. On the New Capacity & Utilization Entry page, ensure that date for the Entering Data For drop-down is
accurate. You can either submit the entry via the web form or upload a data file. The steps below are for
web entry. d.Scroll down to the Therapeutics section, which may look like the following. Please note that therapeutic
reporting data fields are subject to change based on product availability and efficacy against COVID-19
variants.Page 7 of 9
e. Update the current inventory on-hand (in courses) and courses used in the previous week for Regen-
COV (Casirivimab/Imdevimab). For administered doses, the reporting week is Wednesday to Tuesday. Regen-COV Course Calculator: 2.5 mL vials: 4 vials of casirivimab + 4 vials of imdevimab = 1 Patient Course 11 mL vials: 1 vial of casirivimab + 1 vials of imdevimab = 1 Patient Course Dose Packs: 1 packed dose = 1 patient coursef. Update the current inventory on-hand (in courses) and courses used in the previous week for BAM/ETE
(Bamlanivimab/Etsevimab). For administered doses, the reporting week is Wednesday to Tuesday. BAM/ETE Course Calculator: 1 vial of bamlanvimab + 2 vials of etesevimab = 1 Patient Course 1 vial of combined bamlanivimab/etesevimab = 1 Patient Course